WallStreetZenWallStreetZen

NASDAQ: VINC
Vincerx Pharma Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their VINC stock forecasts and price targets.

Forecast return on equity

Is VINC forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is VINC forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

VINC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VINC$0.85N/AN/A
BNTC$6.99$10.00+43.06%Buy
VBIV$0.63N/AN/A
PMCB$2.12N/AN/A
GLTO$0.68N/AN/A

Vincerx Pharma Stock Forecast FAQ

What is VINC's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VINC) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Vincerx Pharma stock.

What is VINC's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VINC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.